Cameco (NYSE:CCJ) Releases Quarterly Earnings Results

Cameco (NYSE:CCJ) (TSE:CCO) posted its quarterly earnings results on Tuesday. The basic materials company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.05, Zacks reports. The company had revenue of $607.49 million for the quarter, compared to analysts’ expectations of $598.63 million. Cameco had a return on equity of 9.35% and a net margin of 17.00%.The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.16 earnings per share.

Here are the key takeaways from Cameco’s conference call:

• Cameco says nuclear momentum is structural, with governments focused on execution and AP1000 technology emerging as the deployment-ready benchmark that should drive long-term fuel demand.
• Progress continues on Westinghouse negotiations with the U.S. government (DOC and DOE tracks), with company involvement in supply‑chain standing‑up and the possibility of up to ~20 U.S. reactors being discussed, though definitive agreements are still in progress.
• Q1 results were in line with expectations and the company left its full-year 2026 guidance unchanged; quarter-over‑quarter gains were mainly timing and higher uranium prices rather than a structural change.
• Operations remain on plan—Canadian production tracking to guidance, JV Inkai back to planned production, and a planned extended Q3 Key Lake shutdown to tie in infrastructure; some supply‑chain cost pressures (e.g., acid) are being monitored but not expected to materially impact 2026.
• Cameco is actively managing supply via inventory and product loans (now over 4 million pounds borrowed) and advancing Global Laser Enrichment (at TRL 6) as a potential Western enrichment/conversion source, supporting long‑term supply diversification.

Cameco Stock Up 8.1%

NYSE:CCJ traded up $9.27 during trading hours on Wednesday, hitting $123.73. 3,760,760 shares of the stock traded hands, compared to its average volume of 3,909,235. The firm has a 50 day moving average price of $114.81 and a 200 day moving average price of $105.52. The company has a current ratio of 2.47, a quick ratio of 1.68 and a debt-to-equity ratio of 0.14. Cameco has a fifty-two week low of $47.87 and a fifty-two week high of $135.24. The firm has a market cap of $53.89 billion, a price-to-earnings ratio of 127.56, a PEG ratio of 2.19 and a beta of 1.04.

More Cameco News

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: Cameco reported Q1 EPS of $0.34 and revenue of $607.5M, both above estimates, with materials and slide-deck details reinforcing operational execution — the core earnings beat is the primary catalyst. Cameco (CCJ) Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: Scotiabank raised its Cameco price target to $175 and cited accelerating demand for nuclear power—this fresh analyst confidence supports near-term upside. Scotiabank Just Hiked Cameco Price Target to $175
• Positive Sentiment: Stifel Canada reiterated a Buy and kept a C$180 target after the quarter, adding institutional support to the stock’s upward move. Cameco Maintained at Buy at Stifel Canada Following Q1 Results; Price Target Kept at C$180
• Positive Sentiment: Independent coverage and upgrades (Seeking Alpha pieces) highlight Cameco’s vertical integration, Westinghouse stake and favorable long-term uranium dynamics — reinforcing the bullish investment thesis. Cameco Corporation: Robust Q1 Results And An Attractive Valuation (Rating Upgrade)
• Neutral Sentiment: Cameco reiterated annual guidance (company says results are consistent with expectations); maintaining guidance reduces downside surprises but offers limited new upside. Cameco Reports First Quarter 2026 Results
• Neutral Sentiment: Company released the earnings slide deck and call materials for investors to review underlying metrics and segment performance (useful for due diligence). Cameco Corporation 2026 Q1 – Results – Earnings Call Presentation
• Negative Sentiment: Valuation is extended after recent gains (high trailing P/E), which could limit near-term upside or increase volatility if uranium/contract dynamics disappoint; investors should weigh price versus fundamentals before adding.

Hedge Funds Weigh In On Cameco

Several institutional investors and hedge funds have recently modified their holdings of the stock. Mcguire Capital Advisors Inc. purchased a new position in shares of Cameco during the 4th quarter valued at $28,000. Corient Private Wealth LLC grew its holdings in shares of Cameco by 1,339.8% during the 4th quarter. Corient Private Wealth LLC now owns 964,552 shares of the basic materials company’s stock valued at $88,247,000 after acquiring an additional 897,558 shares in the last quarter. Alpine Woods Capital Investors LLC grew its holdings in shares of Cameco by 57.6% during the 4th quarter. Alpine Woods Capital Investors LLC now owns 9,766 shares of the basic materials company’s stock valued at $893,000 after acquiring an additional 3,568 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its holdings in shares of Cameco by 9.1% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 11,208 shares of the basic materials company’s stock valued at $1,025,000 after acquiring an additional 939 shares in the last quarter. Finally, Vident Advisory LLC grew its holdings in shares of Cameco by 5.5% during the 4th quarter. Vident Advisory LLC now owns 511,768 shares of the basic materials company’s stock valued at $46,822,000 after acquiring an additional 26,699 shares in the last quarter. 70.21% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on CCJ. Royal Bank Of Canada upped their price target on Cameco from $150.00 to $160.00 and gave the company an “outperform” rating in a report on Tuesday, February 17th. Canadian Imperial Bank of Commerce upped their price target on Cameco to $202.00 in a report on Monday, March 9th. TD Securities downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a research note on Thursday, March 26th. Scotiabank reissued an “outperform” rating and set a $175.00 target price on shares of Cameco in a research note on Wednesday. Finally, Raymond James Financial reissued an “outperform” rating on shares of Cameco in a research note on Wednesday, January 14th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $153.13.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.